Microbiological profile of ventilator-associated pneumonia among intensive care unit patients in tertiary Egyptian hospitals
Related Experiment Video
Updated: Oct 13, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Alaa M Farag1, Mahmoud M Tawfick2, Mostafa Y Abozeed3
1Microbiology and Immunology Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt. alaa244342@hotmail.com.
Introduction:
Ventilator-associated pneumonia (VAP) is one of the common serious infectious diseases encountered in the intensive care unit (ICU), which highly affects the healthcare cost and patient prognosis. VAP is caused by various antimicrobial-resistant aetiological agents and the clinical manifestations lack sensitivity and specificity, making the prompt treatment is a challenge. This study aimed to investigate the microbial profile of VAP causing microorganisms among ICU patients in Egypt, antimicrobial susceptibility patterns and the genetic diversity among the frequently isolated organisms.
Methodology:
Throughout the period from August 2016 to August 2017, endotracheal aspirate (ETA) specimens were collected from ICU patients with clinically suspected VAP in two tertiary hospitals in Cairo. ETA specimens were investigated for the microbial content. The antimicrobial susceptibility was determined by the Kirby-Bauer method. ERIC-PCR was performed for genotyping.
Results:
Fifty microbiologically confirmed VAP cases were identified. The most frequently isolated microorganisms were Klebsiella spp., followed by Pseudomonas aeruginosa, Acinetobacter baumannii. Candida spp. was the most isolated fungi. A single isolate of each Cupriavidus pauculus and Aeromonas salmonicida was isolated. Antimicrobial susceptibility profiles indicated 40% of isolates were multidrug-resistant (MDR). ERIC-PCR revealed no genetic relatedness among K. pneumoniae isolates, the most frequently isolated microorganism.
Conclusions:
Gram-negative bacteria are the main causative agents of VAP cases, which mostly are MDR. Microorganisms like C. pauculus and A. salmonicida should be taken into consideration as VAP causative agents. There was no common source of infection suggesting likely endogenous sources of K. pneumoniae, the main causative agent of VAP in this study.
Insights
Ventilator-associated pneumonia (VAP) in ICUs is often caused by multidrug-resistant Gram-negative bacteria like Klebsiella spp. This study found no common infection source, suggesting endogenous origins for K. pneumoniae.
Area of Science:
- Microbiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Ventilator-associated pneumonia (VAP) is a significant ICU infection with severe consequences.
- Antimicrobial resistance and non-specific symptoms complicate VAP diagnosis and treatment.
- Understanding the microbial landscape of VAP is crucial for effective management.
Purpose of the Study:
- To identify VAP-causing microbes in Egyptian ICUs.
- To analyze antimicrobial susceptibility patterns.
- To assess genetic diversity among common VAP pathogens.
Main Methods:
- Endotracheal aspirates from suspected VAP cases were collected over one year.
- Microbial identification and antimicrobial susceptibility testing (Kirby-Bauer method) were performed.
- Genotyping of frequently isolated organisms was done using ERIC-PCR.
Main Results:
- Fifty VAP cases were confirmed, predominantly caused by Klebsiella spp., Pseudomonas aeruginosa, and Acinetobacter baumannii.
- Candida spp. were the most common fungi; rare isolates included Cupriavidus pauculus and Aeromonas salmonicida.
- Forty percent of isolates exhibited multidrug resistance (MDR).
- No genetic links were found among Klebsiella pneumoniae isolates.
Conclusions:
- Gram-negative bacteria, often multidrug-resistant, are primary VAP agents.
- Cupriavidus pauculus and Aeromonas salmonicida warrant consideration as VAP pathogens.
- The lack of common source suggests endogenous K. pneumoniae infections in this ICU cohort.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Microbiota of the Respiratory Tract
Atypical Pneumonia
Pneumonia I: Introduction

